Remicade®/Janssen/BioAdvance® (CD 2003, UC 2006)
Inflectra®/Pfizer/PfizerFlex (2014)
Renflexis®/Organon/Harmony by Organon™ (2018)
Avsola®/Amgen/Enliven Services (2020)
Remsima®/Celltrion/Celltrion Connect™ (2024)
Monoclonal antibody
Tumour necrosis factor (TNF) blocking agent
IBD causes the immune system to produce an excess amount of TNFα, which causes inflammation. Anti-TNFα is a protein that works to bind TNFα and block inflammation.
Humira®/AbbVie/AbbVie Care (2004)
Abrilada®/Pfizer/Pfizer Flex (2022)
Amgevita®/Amgen/Enliven (2021)
Hadlima®/Organon/Harmony by Organon™ (2021)
Hulio®/Biocon/My Biocon Biologics (2022)
Idacio®/Fresenius Kabi/KabiCare® (2021)
Simlandi™/JAMP Pharma/JAMP Care (2022)
Yuflyma®/Celltrion/Celltrion Connect™ (2022)
Monoclonal antibody
Tumour necrosis factor (TNF) blocking agent
IBD causes the immune system to produce an excess amount of TNFα, which causes inflammation. Anti-TNFα is a protein that works to bind TNFα and block inflammation.
Stelara®/Janssen/BioAdvance® (CD 2017, UC 2020)
Wezlana/Amgen/Enliven Services (2024)
Monoclonal antibody interleukin (IL)-12/23 inhibitor
Targets an overactive immune system by blocking two receptors called IL-12 and IL-23. By blocking these receptors, cells are slowed down, which reduces inflammation.
Monoclonal antibody integrin receptor blocker
Skyrizi®/AbbVie/AbbVie Care (2019)
Monoclonal antibody interleukin (IL)-23 inhibitor
Targets IL-23 protein receptor, which is one of the proteins responsible for inflammation. Blocking this receptor contributes to reducing inflammation.
Rinvoq/Abbvie/Abbvie Care (2023)
JAK Inhibitor
JAKs are intracellular enzymes that activate the body’s immune response causing inflammation. JAK inhibitors block this pathway. Works by attaching to the JAK enzyme to lower its activity and to decrease inflammation in the body.